BriaCell Announces ESMO 2026 Poster on Breast Cancer Biomarker
BriaCell says a poster at ESMO 2026 will highlight a circulating immune biomarker associated with clinical outcomes in metastatic breast cancer.
BriaCell says a poster at ESMO 2026 will highlight a circulating immune biomarker associated with clinical outcomes in metastatic breast cancer.